人免疫缺陷病毒-1整合酶及其抑制剂的研究进展被引量：6

下载PDF

导出

摘要整合酶 (integrase)对于人免疫缺陷病毒 (HIV) 1逆转录病毒的复制来说是必不可少的 ,因而成为抗艾滋病 (AIDS)药物设计的一个理性的靶点。最近文献报道了大量具有抗整合酶活性的化合物。

作者肖苏龙

机构地区北京大学医学部天然药物及仿生药物国家重点实验室

出处《国外医学（药学分册）》 2002年第3期157-161,共5页 Foreign Medical Sciences(Section of Pharmarcy)

基金北京市自然科学基金资助项目 (70 12 0 18) 北京大学创建一流大学基金项目 (985 ) 北京大学生物医学跨学科研究中心项目

关键词人免疫缺陷病毒-1 整合酶抑制剂研究进展艾滋病整合酶抑制剂艾滋病毒

参考文献18

1Mazumder A, Neamati N, Ojwang JO, et al. Inhibition of the human immunodeficiency virus type Ⅰ integrase by guanosine quartet structures [J]. Biochemistry, 1996, 35(43): 13762 - 13771.
2Jing N, Marchand C, Liu J, et al. Mechanism of inhibition of HIV-1 integrase by G-tetrad-forming oligonucleotides in vitro [J]. J Biol Chem, 2000, 275(28):21460-21467.
3Gottfredsson M, Bohjanen PR. Human immunodeficiency virus type Ⅰ as a target for gene therapy[J]. Front Biosci,1997, 2:619- 634.
4d'Angelo J, Mouscadet JF, Desmaele D, et al. HIV-1 integrase: the next target for AIDS therapy[J]? Pathol Biol (Paris), 2001, 49(3) :237 - 246.
5Patrick H, Jonathan L. Retroviral DNA integration [J].Microbiol Mol Biol Rev,1999,63(4):836-843.
6张健慧.HIV整合酶研究进展[J].国外医学（病毒学分册）,1998,5(3):79-83. 被引量：1
7Joseph PG. Retroviral integrase: conserved sequence information as a guide to understanding structure and function of the retroviral and bacterial IS3 DD(35) E transposases [J]. J Mol Struct (Theochem), 1998, 423(1/2) :41 -57.
8Bujacz G, Jaskolski M, Alexandratos J, et al. High-resolution structure of the catalytic domain of avian sarcoma virus integrase[J]. J Mol Biol, 1995, 253(2):333-346.
9Pommier Y, Marchand C, Neamati N. Retroviral integrase inhibitors year 2000: update and perspectives[J]. Antiviral Res, 2000, 47(3): 139 - 148.
10Neamati N, Sunder S, Pommier Y. Design and discovery of HIV-1 integrase inhibitors[J]. Ther Focus, 1997, 2(11):486 - 498.

1Chan D C, Fass D, Berger J M, et al. Core structure of gp41 from the HIV envelope glycoprotein[J]. Cell, 1997,B9: 263.
2Jiang S, Lin K, Zhang L, et al. A screening assay for antiviral compounds targeted to the HIV-1 gp41 core structure using a conformation-specific monoclonal antibody[J]. J Virol Methods, 1999,80 : 85.
3Debnath A K, Lin K, Jiang S. Structure-based identification of small molecule antiviraI compounds targeted to the gp41 core structure of the human immunodeficiency virus type 1 [J]. J Med Chem, 1999,42:3203.
4Eckert D M, Malashkevich V N, Hong I. H, et al. Inhibiting HIV-1 Entry: Discovery of D-Peptide Inhibitors that Target the gp41 Coiled-Coil Pocket[J]. Cell, 1999,99 : 103.
5Daria J, Hazuda P F, Wjtmer M,et al.Inhihitors of strand transfer that prevent integration and inhibit HIV-integase catalytic domain complexed with an inhibitorfa platform for antiviral drug design [J]. Proc Natl Acad Sci USA, 1999,96 : 13040.
6King P J, Ma G, Miao W, et al. Structure-activity relationships; analogues of the dicaffeoylquenic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type-I integrase and replication [J]. J Med Chem, 1999,42,497.
7Sasaki S,Fukushima J, Hamajima K,et al. Clin, Exp Immunol,1998,11(1):30.
8.[EB/OL].中国爱滋病网网址:http://www.aidscn.com.,.
9高琦王琳赵知中.非肽类HIV蛋白酶抑制剂的研究进展[J].药学进展,2002,34(8):635-635.
10.[EB/OL].三九健康网,网址:http://www.39.net.,.

1堵锡华,冯长君.拓扑集成指数与TIBO类衍生物构效关系的研究[J].计算机与应用化学,2007,24(12):1667-1670. 被引量：2
2毕毅,徐进宜,吴晓明.白桦酸类化合物的研究进展[J].中国新药杂志,2005,14(1):23-26. 被引量：8
3吕乃达,王禄林.艾滋病的中医药治疗研究[J].中医药临床杂志,2005,17(4):409-410. 被引量：18
4唐桂兰,吕乃达,杜普.简述中医药治疗艾滋病[J].内蒙古中医药,2005,24(6):33-35. 被引量：8
5王丽华,肖伟洪.乙酸乙酯萃取单宁在玻碳电极上示差脉冲伏安研究[J].江西化工,2006,22(4):112-114.
6张代芬,周青.中医药治疗艾滋病研究概况[J].江西中医药,2007,38(10):61-62. 被引量：4
7金海晓,吴天星,严小军,蒋勇军,邹建卫.抑制剂BD2对PKA与PKCβⅡ的抑制选择性研究[J].化学学报,2009,67(13):1461-1468.
8王红寅,林东强,姚善泾,贠军贤,姚克俭.4-巯乙基吡啶配基与IgG相互作用的分子模拟研究[J].化学学报,2010,68(16):1597-1602. 被引量：8
9叶琛,李泽琳,曾毅.介绍HIV-1整合酶抑制剂研究中几种检测方法[J].中华实验和临床病毒学杂志,2010,24(6):495-497.
10刘畅,谭建军,刘明,张小轶,陈慰祖,王存新.计算机辅助设计抗HIV-1整合酶抑制剂的研究进展[J].生物物理学报,2010,26(12):1088-1100. 被引量：4

国外医学（药学分册）

2002年第3期

内容加载中请稍等...